Acute rheumatic fever in children: Recognition and treatment

Pediatric Drugs

Volumn 6, Issue 6, 2004, Pages 363-373

  Lennon, Diana ^a,b  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

^b South Auckland Mail Centre ^*  (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; AMOXICILLIN; AMPICILLIN; AZITHROMYCIN; BENZATHINE PENICILLIN; C REACTIVE PROTEIN; CARBAMAZEPINE; CHLOROTHIAZIDE; CLARITHROMYCIN; CLINDAMYCIN; CORTICOSTEROID; ERYTHROMYCIN; ERYTHROMYCIN ESTOLATE; ERYTHROMYCIN ETHYLSUCCINATE; FUROSEMIDE; HALOPERIDOL; LIDOCAINE; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; PENICILLIN G; PENICILLIN V; PENICILLIN V POTASSIUM; PHENOBARBITAL; PREDNISONE; SALICYLIC ACID DERIVATIVE; SPIRONOLACTONE; UNINDEXED DRUG; VALPROIC ACID; VANCOMYCIN;

ANAPHYLAXIS; ANTIMICROBIAL THERAPY; BACTERIAL ENDOCARDITIS; BED REST; CLINICAL FEATURE; CLINICAL TRIAL; CORTICOSTEROID THERAPY; COSTA RICA; DEVELOPED COUNTRY; DIFFERENTIAL DIAGNOSIS; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAM; ERYTHROCYTE SEDIMENTATION RATE; HEALTH CARE COST; HEART REHABILITATION; HUMAN; HYPERPNEA; IMMUNOASSAY; INCIDENCE; INFLAMMATION; LIVER TOXICITY; META ANALYSIS; MOBILIZATION; PATIENT REFERRAL; PENICILLIN ALLERGY; PHARYNGITIS; PHYSICAL EXAMINATION; PRIMARY PREVENTION; PRIORITY JOURNAL; PROGNOSIS; REVIEW; RHEUMATIC FEVER; RHEUMATIC HEART DISEASE; SECONDARY PREVENTION; STREPTOCOCCUS; SYSTEMATIC REVIEW; THORAX RADIOGRAPHY; THROAT CULTURE; TINNITUS;

ACUTE DISEASE; AGE FACTORS; CHILD; HUMANS; META-ANALYSIS; NEW ZEALAND; RHEUMATIC FEVER;

EID: 11244349061     PISSN: 11745878     EISSN: None     Source Type: Journal    
DOI: 10.2165/00148581-200406060-00004     Document Type: Review

References (32)

1. Special Writing Group. Guidelines for the diagnosis of rheumatic fever: Jones criteria, 1992 update. JAMA 1992; 268: 2069-73
2. Voss LM, Wilson NJ, Neutze JM, et al. Intravenous immunoglobulin in acute rheumatic fever: a randomized controlled trial. Circulation 2001; 103 (3): 401-6
3. Lennon D. Acute rheumatic fever. In: Feigin R, Cherry J, editors. Textbook of pediatric infectious diseases. 4th ed. Philadelphia (PA): WB Saunders, 2004: 371-84
4. Steer AC, Carapetis JR, Nolan TM, et al. Systematic review of rheumatic heart disease prevalence in children in developing countries: the role of environmental factors. J Paediatr Child Health 2002; 38: 229-34
5. Veasy LG, Wiedmeier SE, Ormond GS, et al. Resurgence of acute rheumatic fever in the intermountain area of the United States. N Engl J Med 1987; 316: 421-7
6. World Health Organization. Rheumatic fever and rheumatic heart disease. Report of a WHO Expert Consultation; 2001 Oct 29-Nov 1; Geneva
7. Kumar R. Controlling rheumatic heart disease in developing countries. World Health Forum 1995; 16: 47-51
8. Vendsborg P, Fauerholdt L, Olsen KH. Decreasing incidence of a history of acute rheumatic fever in chronic rheumatic heart disease. Cardiologica 1968; 53: 332-40
9. McNicholas A, Lennon D. Overcrowding and infectious diseases. N Z Med J 2000; 113: 453-4
10. Gordis L. Effectiveness of comprehensive-care programs in preventing rheumatic fever. N Engl J Med 1973; 289: 331-5
11. De Cunto CL, Giannini EH, Fink CW, et al. Prognosis of children with post-streptococcal reactive arthritis. Pediatr Infect Dis J 1988; 7: 683-6
12. Finals RS. Polyarthritis and fever. N Engl J Med 1994; 330: 769-74
13. Wilson NJ, Neutze JM. Echocardiographic diagnosis of subclinical carditis in acute rheumatic fever. Int J Cardiol 1995; 50: 1-6
14. Ferrieri P, Jones Criteria Working Group. Proceedings of the Jones Criteria Workshop. Circulation 2002; 106: 2521-3
15. Abernethy M, Bass N, Sharpe N, et al. Doppler echocardiography and the early diagnosis of carditis in acute rheumatic fever. Aust NZJ Med 1994; 24: 530-5
16. Siegel AC, Johnson EE, Stollerman GH. Controlled studies of streptococcal pharyngitis in a pediatric population. N Engl J Med 1961; 265: 559-66
17. Kaplan EL, Top FH, Dudding BA, et al. Diagnosis of streptococcal pharyngitis: differentiation of active infection from the carrier state in the symptomatic child. J Infect Dis 1971; 123: 490-501
18. Martin D, Dawson K. Streptococcal serology. N Z Med J 1981; 94: 134-7
19. Shet A, Kaplan EL. Clinical use and interpretation of group A streptococcal antibody tests: a paediatrician or primary care physician. Pediatr Infect Dis J 2002; 21: 420-30
20. Kaplan EL, Rothermel CD, Johnson DR. Antistreptolysin O and anti-deoxyribonuclease B titres: normal values for children ages 2 to 12 in the United States. Pediatrics 1998; 101: 86-8
21. Albert DA, Hafel L, Karrison T. The treatment of rheumatic carditis: a review and meta-analysis. Medicine 1995; 74: 1-12
22. Uziel Y, Hashkes PJ, Kassem E, et al. The use of naproxen in the treatment of children with rheumatic fever. J Pediatr 2000; 137: 269-71
23. Park MK. Paediatric cardiology for practitioners. 3rd ed. St Louis (MO): Mosby Year Book, 1996
24. Bisno AL, Gerber MA, Gwaltney JM, et al. Practice guidelines for the diagnosis and management of group A streptococcal pharyngitis. Clin Infect Dis 2002; 35: 113-25
25. Amir J, Ginat S, Cohen YH, et al. Lidocaine as a diluent for administration of benzathine penicillin. Pediatr Im Dis J 1998; 17: 890-3
26. Lennon D, as member of Rheumatic Fever Working Party. Rheumatic fever secondary prophylaxis: circular letter to medical practitioners (HP 2/87). Wellington: New Zealand Department of Health, 1987
27. Pickering LK, Baker CJ, Overrurf GD, et al. Red Book: 2003 Report of the Committee on Infectious Diseases. 26th ed. Elk Grove Village (IL): American Academy of Pediatrics, 2003: 526-36
28. Lue H, Wu M, Wang J, et al. Long-term outcome of patients with rheumatic fever receiving benzathine penicillin prophylaxis every three weeks versus every four weeks. J Pediatr 1994; 125: 813-7
29. Berrios A, del Campo E, Guzman B, et al. Discontinuing rheumatic fever prophylaxis in selected adolescents and young adults: a prospective study. Ann Intern Med 1993; 118: 401-6
30. Dajani AS, Taubert KA, Wilson W, et al. Prevention of bacterial endocarditis: recommendations by the American Heart Association. JAMA 1997; 277: 1794-801
31. Denny FW, Wannamaker LW, Brink WR, et al. Prevention of rheumatic fever: treatment of the preceding streptococcal infection. JAMA 1950; 143: 151-3
32. Kotloff KL, Corretti M, Palmer K, et al. Safety and immunogenicity of a recombinant multivalent Group A streptococcal vaccine in healthy adults: phase I trial. JAMA 2004; 292 (6): 709